Report
Patrik Ling
EUR 92.37 For Business Accounts Only

Getinge (Hold, TP: SEK245.00) - 2023 set to be back-end loaded

Q4 earnings were broadly in line with expectations, with slightly stronger sales but a slightly weaker adj. EBITA margin. The 2023 guidance is for 2–5% organic sales growth, and management indicated it expected a small margin improvement in the year, basically in line with consensus. It also expects 2023 to be back-end loaded, with a tougher comparable in H1 than H2. We reiterate our HOLD, but have edged up our target price to SEK245 (240) after making minor estimate changes following the Q4 report.
Underlying
Getinge AB Class B

Getinge is engaged in three business areas: Medical Systems, Extended Care and Infection Control. Medical System's product range includes surgical tables, surgical lamps, telemedicine, perfusion products, instruments for bypass operations, ventilators, anesthesia systems, synthetic vascular implants and stents. Extended Care's product range includes bathing and shower solutions, lifting equipment and mattresses for the treatment and prevention of pressure ulcers, as well as service and consulting. Infection Control's product range comprises disinfectors, sterilizers, information technology systems and related equipment, as well as service and consulting.

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Patrik Ling

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch